Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia.
NCT02107092
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
123
Enrollment
INDUSTRY
Sponsor class
Conditions
Hyperkalemia
Interventions
DRUG:
Sodium Zirconium Cyclosilicate
Sponsor
ZS Pharma, Inc.